For decades, the regulation and control of new drugs in the United States has been based on the New Drug Application (NDA). Since 1938, every new drug has been the subject of an approved NDA before U.S. commercialization. The NDA application is the vehicle through which drug sponsors formally propose that the FDA approve a new pharmaceutical for sale and marketing in the U.S.
New Drug Application
Share / Follow
Recent Blogs
The Dream of the 90s is Alive at CBER
OraSure's at-home HIV test delivers on 20 years of effort
In-Vehicle Diagnostics
Assessing the bold future of automotive medicine
Great New Companion Diagnostics E-Book Released Today
A valuable resource in a hot, but under-informed segment of the market
Oragene Clearance Shows DNA Stabilization is Class II
Clearance could have a significant impact on DTCG providers